G-III Apparel’s FY2026 Earnings Projection Falling Below Consensus Estimate

The fiscal year 2026 earnings projection for G-III Apparel is currently at $2.55-$2.75 per share. This falls below the consensus estimate of $2.90. Following this projection, G-III Apparel stock has experienced an increase of $0.09 (+0.33%), with the current stock price standing at $27.12. Furthermore, the company anticipates its revenue for FY26 to be around $3.02 billion.

Perspective Therapeutics has made a noteworthy move by appointing Joel Sendek as its new Chief Financial Officer. Following this announcement, the shares of the company have risen by $0.06 (+1.81%), raising the stock price to $3.38.

Speaking on the financial index, the DXY has seen some activities worth noting. Meanwhile, G-III Apparel’s performance continues to make headlines, with a Q2 earnings per share (EPS) of 25c, surpassing the consensus of 9c. The current stock price for G-III Apparel sits at $27.12, marking an increase of $0.09 (+0.33%).

Looking at the projections for Brady, the FY26 adjusted EPS is estimated at $4.85-$5.15, compared to a two estimate average of $4.92. Brady’s stock currently stands at $77.70, seeing a slight decrease of $0.09 (-0.12%). Various calculations and assumptions were taken into account for these projections.

Palantir’s Foundry and Advanced Ingestion Process (AIP) have been adopted by Lumen. The market has reacted to this news, with Palantir’s shares dropping $2.19 (-1.39%) to $154.90, and Lumen’s stocks also decreasing by $0.07 (-1.46%) to $4.72.

SAIC has reported its Q2 adjusted EPS at $3.63, going far beyond the consensus of $2.24. Moreover, SAIC’s stock price currently sits at $114.11, showing a drop of $4.16 (-3.52%). The company is yet to release its report on Q2 revenue.

Guggenheim has initiated the coverage of Summit Therapeutics by instigating a ‘Buy’ rating, and anticipates multi-fold upside potential. However, Summit Therapeutic’s shares have witnessed a decline of $0.32 (-1.34%) to a trading rate of $23.52. In contrast, Merck shares have observed a drop of $1.3 (-1.52%) to $84.18.

In FY2026 report, Brady’s Q4 adjusted earnings per share (EPS) stood at $1.26, which was slightly greater than what was reported for the same period last year – $1.19. Brady, with the stock figure currently set at $77.70, experienced a minor decrease, losing about $0.09 (-0.12%).

VersaBank has reported Q3 adjusted EPS of C$0.30, taking a slight dip from C$0.36 last year. VersaBank’s shares have gone up $0.34 (+3.09%), putting the stock at $11.36. The company is expected to announce reports on their Q3 revenue.

A five-year partnership expansion has been confirmed between Palantir and Lear. The stock market has responded with Palantir’s stock declining by $2.19 (-1.39%), settling at $154.90. Lear experienced a similar downward trajectory, losing $0.81 (-0.74%) and landing at $108.44.

According to JPMorgan, the demand for Nvidia products continues to exceed its supply. Nevertheless, Nvidia’s stock has dipped slightly – $0.16 (-0.09%) – with the current trading price at $170.62.

Citi has increased the price target for DocuSign by $5. The outcome of this announcement is reflected in DocuSign’s stock, which increased by $1.83 (+2.47%), raising the stock to $75.90.

On contrary, GitLab’s price target has been cut by UBS by $13, leading to the stock dipping $0.78 (-1.64%), with the present stock value at $46.91.

Further on company forecasts, Credo Technology has had its price target raised by $20 at Mizuho. This news triggers a positive effect on the Credo’s stock, as it increased $0.5 (+0.40%) to $124.77.

The Buckle reported an increase of 12.2% in their August SSS. This news has positively influenced The Buckle’s stocks, increasing it by $0.28 (+0.49%) to $57.78.

C3 AI has had its price target lowered by UBS by $7, with its stock experiencing a decline of $0.14 (-0.83%) to $16.68. In another piece of noteworthy news, 1-800-Flowers.com has posted its Q4 adjusted EPS of (69c), falling short of the consensus which was (51c). This has resulted in the e-commerce company’s stock to decline by $0.25 (-4.48%) to $5.33.